OptimizeRx (NASDAQ:OPRX) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
OptimizeRx missed estimated earnings by 12.5%, reporting an EPS of $-0.09 versus an estimate of $-0.08.
Revenue was down $729 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 11.64% drop in the share price the next day.
Here’s a look at OptimizeRx’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.24 | 0.04 | 0.09 | -0.01 |
| EPS Actual | 0.25 | 0.07 | 0.04 | -0.01 |
| Revenue Estimate | 21.77M | 15.02M | 16.87M | 13.97M |
| Revenue Actual | 19.65M | 15.09M | 13.98M | 13.73M |
To track all earnings releases for OptimizeRx visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
